Has Bard Access Systems, Inc. had other FDA enforcement actions?

Yes. Argus HQ has recorded 17 total FDA actions tied to Bard Access Systems, Inc.: 0 warning letters, 17 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged critical severity by Argus HQ. FDA published the underlying record on 2026-09-23; Argus observed and indexed it on 2026-09-29.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · device_recall · critical

Bard Access Systems, Inc. — Class I recall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150; DuoGlide Short-Te…

Name: FDA Recall Record — Bard Access Systems, Inc.
Creator: Argus HQ
Published: 2026-09-23
License: https://argushq.ai/methodology

Event date: 2026-09-23 00:00:00Z
Observed: 2026-09-29 04:20:38Z
Source ID: Z-2985-2026
Payload hash: ddec99a8027babe3b0100344…

Summary

this is a downstream recall of class I recall RES 98777 Status: Ongoing.

Entities

Bard Access Systems, Inc.

View source record ↗

Frequently asked questions

Has Bard Access Systems, Inc. had other FDA enforcement actions?: Yes. Argus HQ has recorded 17 total FDA actions tied to Bard Access Systems, Inc.: 0 warning letters, 17 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged critical severity by Argus HQ. FDA published the underlying record on 2026-09-23; Argus observed and indexed it on 2026-09-29.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Bard Access Systems, Inc. — Class I recall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150;  DuoGlide Short-Te…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-bard-access-systems-inc-z-2985-2026

MLA

"Bard Access Systems, Inc. — Class I recall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150;  DuoGlide Short-Te…." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-recall-bard-access-systems-inc-z-2985-2026.

Chicago

Argus HQ Research. "Bard Access Systems, Inc. — Class I recall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150;  DuoGlide Short-Te…." Digital Empire Holdings LLC. Accessed September 29, 2026. https://argushq.ai/events/fda-recall-bard-access-systems-inc-z-2985-2026.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_bard_access_systems_inc_z_2985_2026_2026,
  title = {Bard Access Systems, Inc. — Class I recall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150;  DuoGlide Short-Te…},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-bard-access-systems-inc-z-2985-2026},
  note = {Accessed: September 29, 2026}
}

Informational only. Not legal, financial, or medical advice.